Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population.

[1]  S. McGuire.  World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. , 2016, Advances in nutrition.

[2]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[3]  Sandra Zazo,et al.  Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer , 2015, BMC Pulmonary Medicine.

[4]  Zhiyong Wu,et al.  Prognostic significance of the mRNA expression of ERCC1, RRM1, TUBB3 and TYMS genes in patients with non-small cell lung cancer. , 2015, Experimental and therapeutic medicine.

[5]  L. Partridge,et al.  The Hallmarks of Aging , 2013, Cell.

[6]  J. Wu,et al.  Polymorphism rs7214723 in CAMKK1 and lung cancer risk in Chinese population , 2013, Tumor Biology.

[7]  A. Zhavoronkov,et al.  The role of DNA damage and repair in aging through the prism of Koch-like criteria , 2013, Ageing Research Reviews.

[8]  S. Venitt,et al.  DNA and protein adducts in human tissues resulting from exposure to tobacco smoke , 2012, International journal of cancer.

[9]  Stephen S Hecht,et al.  Lung carcinogenesis by tobacco smoke , 2012, International journal of cancer.

[10]  C. Gridelli,et al.  Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  J. Ahn,et al.  Significance of Thymidylate Synthase and Thyroid Transcription Factor 1 Expression in Patients with Nonsquamous Non-small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  Paolo Boffetta,et al.  Genetics of lung-cancer susceptibility. , 2011, The Lancet. Oncology.

[13]  P. Brennan,et al.  Family history and lung cancer risk: international multicentre case–control study in Eastern and Central Europe and meta-analyses , 2010, Cancer Causes & Control.

[14]  G. Scagliotti,et al.  Non-small cell lung cancer exhibits transcript overexpression of genes associated with homologous recombination and DNA replication pathways. , 2009, Cancer research.

[15]  J. Long,et al.  Association of Thymidylate Synthase Gene with Endometrial Cancer Risk in a Chinese Population , 2009, Cancer Epidemiology Biomarkers & Prevention.

[16]  A. Neugut,et al.  Polymorphisms of one-carbon-metabolizing genes and risk of breast cancer in a population-based study. , 2007, Carcinogenesis.

[17]  J. Robert,et al.  Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel. , 2007, European journal of cancer.

[18]  N. Kim,et al.  Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population. , 2006, Anticancer research.

[19]  G. Scagliotti,et al.  Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase , 2006, Cancer.

[20]  Hongbing Shen,et al.  Polymorphisms in thymidylate synthase gene and susceptibility to breast cancer in a Chinese population: a case-control analysis , 2006, BMC Cancer.

[21]  K. Matsuo,et al.  One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. , 2005, Carcinogenesis.

[22]  C. Ulrich,et al.  Polymorphisms in the Reduced Folate Carrier, Thymidylate Synthase, or Methionine Synthase and Risk of Colon Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  Qiuling Shi,et al.  Case-control analysis of thymidylate synthase polymorphisms and risk of lung cancer. , 2004, Carcinogenesis.

[24]  M. Fukushima,et al.  Expression of thymidylate synthase is correlated with proliferative activity in non-small cell lung cancer (NSCLC). , 2004, Lung cancer.

[25]  Rebecca A Mosig,et al.  Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  B. Dolnick,et al.  A Novel Function for the rTS gene , 2003, Cancer biology & therapy.

[27]  B. Dolnick,et al.  Natural antisense (rTSalpha) RNA induces site-specific cleavage of thymidylate synthase mRNA. , 2002, Biochimica et biophysica acta.

[28]  H. Blomgren,et al.  Thymidylate synthase expression: an independent prognostic factor for local recurrence, distant metastasis, disease-free and overall survival in rectal cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  C. Allegra,et al.  The role of thymidylate synthase as an RNA binding protein , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[30]  B. Dolnick,et al.  Cloning and characterization of a naturally occurring antisense RNA to human thymidylate synthase mRNA. , 1993, Nucleic acids research.

[31]  A. Lilienfeld,et al.  Familial aggregation of lung cancer in humans. , 1963, Journal of the National Cancer Institute.

[32]  A. Schwartz,et al.  Epidemiology of Lung Cancer. , 2016, Advances in experimental medicine and biology.

[33]  R. Wolfe,et al.  Homocysteine metabolism. , 1999, Annual review of nutrition.